These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30312846)

  • 1. An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo.
    Cen B; Wei Y; Huang W; Teng M; He S; Li J; Wang W; He G; Bai X; Liu X; Yuan Y; Pan X; Ji A
    Mol Ther Nucleic Acids; 2018 Dec; 13():220-232. PubMed ID: 30312846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bivalent cyclic RGD-siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts.
    Liao L; Cen B; Li G; Wei Y; Wang Z; Huang W; He S; Yuan Y; Ji A
    Drug Deliv; 2021 Dec; 28(1):1432-1442. PubMed ID: 34236267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIK3CB/p110β is a selective survival factor for glioblastoma.
    Pridham KJ; Le L; Guo S; Varghese RT; Algino S; Liang Y; Fajardin R; Rodgers CM; Simonds GR; Kelly DF; Sheng Z
    Neuro Oncol; 2018 Mar; 20(4):494-505. PubMed ID: 29016844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.
    Esposito CL; Nuzzo S; Catuogno S; Romano S; de Nigris F; de Franciscis V
    Mol Ther Nucleic Acids; 2018 Mar; 10():398-411. PubMed ID: 29499951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo.
    Pu P; Kang C; Zhang Z; Liu X; Jiang H
    Technol Cancer Res Treat; 2006 Jun; 5(3):271-80. PubMed ID: 16700623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA.
    Liu X; Wang W; Samarsky D; Liu L; Xu Q; Zhang W; Zhu G; Wu P; Zuo X; Deng H; Zhang J; Wu Z; Chen X; Zhao L; Qiu Z; Zhang Z; Zeng Q; Yang W; Zhang B; Ji A
    Nucleic Acids Res; 2014 Oct; 42(18):11805-17. PubMed ID: 25223783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway.
    Cen B; Liao W; Wang Z; Gao L; Wei Y; Huang W; He S; Wang W; Liu X; Pan X; Ji A
    Mol Ther Nucleic Acids; 2018 Jun; 11():300-311. PubMed ID: 29858065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival kinase genes present prognostic significance in glioblastoma.
    Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
    Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
    Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
    ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
    Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
    Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
    Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
    J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
    Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
    Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats].
    Deng YZ; Liu SJ; Ma L; Sun ZQ; Chen JJ; Su G; Liu C; Wang GH; Ke J
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1713-6. PubMed ID: 17825157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT.
    Mecca C; Giambanco I; Bruscoli S; Bereshchenko O; Fioretti B; Riccardi C; Donato R; Arcuri C
    Front Cell Neurosci; 2018; 12():99. PubMed ID: 29692710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connexin 43 confers chemoresistance through activating PI3K.
    Pridham KJ; Shah F; Hutchings KR; Sheng KL; Guo S; Liu M; Kanabur P; Lamouille S; Lewis G; Morales M; Jourdan J; Grek CL; Ghatnekar GG; Varghese R; Kelly DF; Gourdie RG; Sheng Z
    Oncogenesis; 2022 Jan; 11(1):2. PubMed ID: 35022385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.
    Pridham KJ; Varghese RT; Sheng Z
    Front Oncol; 2017; 7():312. PubMed ID: 29326882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys).
    Alves S; Correia JD; Gano L; Rold TL; Prasanphanich A; Haubner R; Rupprich M; Alberto R; Decristoforo C; Santos I; Smith CJ
    Bioconjug Chem; 2007; 18(2):530-7. PubMed ID: 17373771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.